Table 2 Measures table

Knowledge and attitude about patient-centered care, SDM, use of DSTs

Pre and post survey of providers

Semi-structured interviews

90 min. CME interactive orientation sections with providers and exit interviews

Descriptive pre-post analysis

Thematic analysis of transcribed interviews using Dedoose

Pre and post physician education

End of study

Medication adherence

Medication Events Monitoring Systems ( eCap).

Cronbach’s alpha=.0.85

ARMS Survey

eCap upload to BRIC

RA will administer form to patient pre/post intervention to evaluate treatment medication adherence

Linear or generalized linear mixed effects model and Beta regression to evaluate changes over time for groups 1 and 2

Baseline, 6 and 12 months

Patient Activation Measure Scores/Level

Patient Activation Measure (PAM) Cronbach’s alpha=.91

RA administers form to patient pre and post intervention

Linear or generalized linear mixed effects model for change overtime for groups 1 and 2

Baseline, 6 and 12 months

Self-Efficacy Scores

Stanford 6-Item Self Efficacy Scale

Summary DM Self-Activities Measure (SDSCA)

RA administers form to patient pre and post intervention to evaluate change in self-efficacy

Linear or generalized linear mixed effects models for change over time for groups 1 and 2

Baseline, 6 and 12 months

Rate of use of aspirin/antiplatelets, beta-blockers, ACEI/ARBs, cholesterol assessment and treatment, DM medications

PAI agreement in chart

Patient medication list

Patient medical record

Texting log

Chart audits to compare the rate of use of aspirin/antiplatelets, beta-blockers, ACEI, cholesterol assessment and treatment of DM

Linear or generalized linear mixed effects model for change overtime for groups 1 and 2

Baseline, 6 and 12 months

Rate of BP control

Diabetic Control (HbA1c)

Digital sphygmomanometer , HbA1c assessment in the community lab using standard instrument

Three BP measurements, 1 minute intervals, using appropriate cuff Reliable point-of-care HbA1c test

Linear or generalized linear mixed effects model for change overtime for groups 1 and 2

Average BP and HbA1c at baseline, 6 and 12 months

Combined Outcome Measure for Risk Communication & Treatment Decision Making Effectiveness (COMRADE)

COMRADE questionnaire

Cronbach’s alpha=.92

CollaboRate SDM Measure

RA administers form pre/post intervention to evaluate satisfaction with shared decision-making

Linear or generalized linear mixed effects model for change overtime for groups 1 and 2

COMRADE use at baseline, 6 and 12 months

PAI + Texting use rate & acceptability rating by clinical staff

PAI agreement forms; Texting log; pre/post physician/staff surveys; physician/staff interviews

RA records and chart abstraction to determine PAI + Texting use

Staff meeting and survey to explore adoption + practice diary entries

Determine rate of use of PAI +Texting

Frequencies of responses to evaluation surveys

Chart Abstraction at 6 months. RA tracks rates throughout study